Key facts
- Third Rock Ventures V, L.P. filed SCHEDULE 13G for Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP).
- Disclosed ownership: 20%.
- Date of event: 31 Dec 2024.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. | 20% | 7,135,233 | 0 | 7,135,233 | /s/ Kevin Gillis | Kevin Gillis, COO of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P. | |
| Third Rock Ventures GP V, L.P. | 20% | 7,135,233 | 0 | 7,135,233 | /s/ Kevin Gillis | Kevin Gillis, Chief Operating Officer of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P | |
| TRV GP V, LLC | 20% | 7,135,233 | 0 | 7,135,233 | /s/ Kevin Gillis | Kevin Gillis, Chief Operating Officer of TRV GP V, LLC | |
| Third Rock Ventures VI, L.P. | 2.7% | 969,218 | 0 | 969,218 | /s/ Kevin Gillis | Kevin Gillis, COO of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P., general partner of Third Rock Ventures VI, L.P. | |
| Third Rock Ventures GP VI, L.P. | 2.7% | 969,218 | 0 | 969,218 | /s/ Kevin Gillis | Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P. | |
| TRV GP VI, LLC | 2.7% | 969,218 | 0 | 969,218 | /s/ Kevin Gillis | Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC |
CIK / CUSIP context first